Personalized cancer therapy using a patient-derived tumor tissue xenograft model: a translational field worthy of exploring further?
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Personalized cancer therapy using a patient-derived tumor tissue xenograft model: a translational field worthy of exploring further?
Authors
Keywords
-
Journal
Personalized Medicine
Volume 7, Issue 5, Pages 597-606
Publisher
Future Medicine Ltd
Online
2010-09-29
DOI
10.2217/pme.10.48
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparative Profiling of the Novel Epothilone, Sagopilone, in Xenografts Derived from Primary Non-Small Cell Lung Cancer
- (2010) S. Hammer et al. CLINICAL CANCER RESEARCH
- Antitumor Effects and Biomarkers of Activity of AZD0530, a Src Inhibitor, in Pancreatic Cancer
- (2009) N.V. Rajeshkumar et al. CLINICAL CANCER RESEARCH
- Utilizing the Molecular Gateway: The Path to Personalized Cancer Management
- (2009) J. B. Overdevest et al. CLINICAL CHEMISTRY
- American Society of Clinical Oncology Provisional Clinical Opinion: Testing forKRASGene Mutations in Patients With Metastatic Colorectal Carcinoma to Predict Response to Anti–Epidermal Growth Factor Receptor Monoclonal Antibody Therapy
- (2009) Carmen J. Allegra et al. JOURNAL OF CLINICAL ONCOLOGY
- Tamoxifen Resistance in Breast Tumors Is Driven by Growth Factor Receptor Signaling with Repression of Classic Estrogen Receptor Genomic Function
- (2008) S. Massarweh et al. CANCER RESEARCH
- Effect of Rapamycin Alone and in Combination with Sorafenib in an Orthotopic Model of Human Hepatocellular Carcinoma
- (2008) Z. Wang et al. CLINICAL CANCER RESEARCH
- CYP450 pharmacogenetics for personalizing cancer therapy
- (2008) Ron H.N. van Schaik DRUG RESISTANCE UPDATES
- Xenografts of primary human gynecological tumors grown under the renal capsule of NOD/SCID mice show genetic stability during serial transplantation and respond to cytotoxic chemotherapy
- (2008) Joshua Z. Press et al. GYNECOLOGIC ONCOLOGY
- The Evidence Dilemma In Genomic Medicine
- (2008) Muin J. Khoury et al. HEALTH AFFAIRS
- Role of Genetic and Nongenetic Factors for Fluorouracil Treatment-Related Severe Toxicity: A Prospective Clinical Trial by the German 5-FU Toxicity Study Group
- (2008) Matthias Schwab et al. JOURNAL OF CLINICAL ONCOLOGY
- Bevacizumab and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma
- (2008) Hung Huynh et al. JOURNAL OF HEPATOLOGY
- Proteomic Contributions to Personalized Cancer Care
- (2008) John M. Koomen et al. MOLECULAR & CELLULAR PROTEOMICS
- Current Status of Prognostic Profiling in Breast Cancer
- (2008) L. Pusztai ONCOLOGIST
- Direct Orthotopic Transplantation of Fresh Surgical Specimen Preserves CD133+Tumor Cells in Clinically Relevant Mouse Models of Medulloblastoma and Glioma
- (2008) Qin Shu et al. STEM CELLS
- Initial testing of the VEGFR inhibitor AZD2171 by the pediatric preclinical testing program
- (2007) John M. Maris et al. PEDIATRIC BLOOD & CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started